LabTurbo Biotech (ROCO:7725) Other Current Receivables: NT$3.34 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7725 LabTurbo Biotech Corp ROCO:7725
42 GF Score
Price NT$23.50
GF Value NT$28.42
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is LabTurbo Biotech Other Current Receivables?

LabTurbo Biotech ROCO:7725 42 Other Current Receivables is NT$3.34 Mil as of Jun. 2026. GuruFocus rates ROCO:7725 with a GF Score™ of 42/100 and a GF Value™ of NT$28.42 (Modestly Undervalued). The stock has 2 warning signs investors should review.

LabTurbo Biotech's Other Current Receivables for the quarter that ended in Jun. 2026 was NT$3.34 Mil.

LabTurbo Biotech's quarterly Other Current Receivables declined from Jun. 2025 (NT$22.53 Mil) to Dec. 2025 (NT$1.39 Mil) but then increased from Dec. 2025 (NT$1.39 Mil) to Jun. 2026 (NT$3.34 Mil).

LabTurbo Biotech's annual Other Current Receivables declined from Dec. 2023 (NT$16.23 Mil) to Dec. 2024 (NT$6.81 Mil) and declined from Dec. 2024 (NT$6.81 Mil) to Dec. 2025 (NT$1.39 Mil).

LabTurbo Biotech Other Current Receivables Related Terms

LabTurbo Biotech Other Current Receivables Historical Data

* Premium members only.

The historical data trend for LabTurbo Biotech's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LabTurbo Biotech Other Current Receivables Chart

LabTurbo Biotech Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
0.87 9.43 16.23 6.81 1.39

LabTurbo Biotech Semi-Annual Data
Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only 13.35 6.81 22.53 1.39 3.34
ROCO:7725
42GF Score
LabTurbo Biotech Corp ROCO:7725
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LabTurbo Biotech Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of NT$3.34 Mil mean?
LabTurbo Biotech (ROCO:7725) has a Other Current Receivables of NT$3.34 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on LabTurbo Biotech and its competitors.
Is LabTurbo Biotech's Other Current Receivables too high?
LabTurbo Biotech's current Other Current Receivables is NT$3.34 Mil. Overall, LabTurbo Biotech has a GF Score™ of 42/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LabTurbo Biotech's Other Current Receivables compare to VRTX and REGN?
LabTurbo Biotech's Other Current Receivables of NT$3.34 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on LabTurbo Biotech and its competitors. LabTurbo Biotech's current Other Current Receivables is NT$3.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LabTurbo Biotech stock overvalued right now?
Based on GuruFocus' analysis, LabTurbo Biotech (ROCO:7725) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$28.42, compared to a current price of NT$23.50 — trading 17.3% below its estimated fair value. The current Other Current Receivables is NT$3.34 Mil. LabTurbo Biotech's overall GF Score™ is 42/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For LabTurbo Biotech (ROCO:7725), the current Other Current Receivables is NT$3.34 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LabTurbo Biotech (ROCO:7725) Overvalued in 2026?

Based on GuruFocus' analysis, LabTurbo Biotech stock appears to be undervalued. The current stock price of NT$23.50 is trading 17.3% below its estimated GF Value™ of NT$28.42. GuruFocus considers LabTurbo Biotech to be Modestly Undervalued.

Key valuation signals for ROCO:7725:

  • Other Current Receivables: NT$3.34 Mil
  • GF Value™: NT$28.42 vs. price of NT$23.50 (17.3% below fair value)
  • GF Score™: 42/100 with 2 warning signs

No single metric tells the full story. See the ROCO:7725 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

LabTurbo Biotech Business Description

Address 3F-1, No. 150, Section 4, Chengde Road, Shilin District, Taipei, TWN
LabTurbo Biotech Corp is a company that is mainly engaged in the research and development, production, sales of nucleic acid extraction, genetic testing, genetic testing reagents, instruments, and the operation of sports science venues. Its main products and services include the entire process. Automated precision medical genetic testing systems and reagent kits as well as testing services.
42GF Score

Get the complete analysis for ROCO:7725

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$23.50
Price
NT$28.42
GF Value